Latest News Archive

Please select Category, Year, and then Month to display items

Innovative wool creations shine at Karoo Winter Wool Festival

25 June 2024 | Story Martinette Brits | Photo Carine van Zyl

OVK Innovation Competition Gala Event 2024 — The prize winners at the gala evening of the OVK Innovation Competition on 13 June 2024. From the left, in front: Emily Segame, Sophia Mekhoe, Sarah Lenong, Maserame Sebonyane, Ntabiseng Ndabeni. At the back: Elizabeth Mnwana, Carlize van Zyl (winner of the competition), Carien Vorster, Jana Vermaas, Doretha Jacobs, and Nelly Olayi.

The University of the Free State (UFS) Wool Wise Community Project was recognised for its innovative use of wool, receiving accolades at the OVK Innovation Competition held in conjunction with the Karoo Winter Wool Festival in Middelburg from 13–16 June 2024.According to Carien Vorster, project manager from the Department of Sustainable Food Systems and Development, participants were tasked with crafting practical items from wool. Their creativity shone through in their design of a lampshade, earning them second place. Doretha Jacobs, a lecturer in the Department of Sustainable Food Systems and Development, focused on making felt from Dorper fibre, noting that while Dorper sheep are primarily bred for meat, they sought to repurpose fibres that would otherwise be discarded.

The team achieved third place with their cushion, featuring a front made entirely of merino wool felt and a back crafted from upholstery fabric. “Each cushion contains a 100% duck feather inner, and their uniqueness lies in the hand-dyed wool and hand-placed designs on each felt piece,” explains Vorster.

Other notable entries from different teams included a duvet inner, shoe insoles, and oven gloves. The top prize went to a hand-felted coat.

Community project empowers local women in wool craft

The UFS Wool Wise Community Project originated as a spin-off from the Regional Universities Forum for Capacity Building (Ruforum) project, initiated in 2019 by the UFS Department for Sustainable Food Systems and Development.

According to Vorster, the Ruforum project encompasses various components such as research, farmer support, and community development, with a particular emphasis on community upliftment programmes. "Since 2019, we have conducted numerous wool workshops and training sessions where local women have participated to learn about wool processing," she explains.

"From these events, we identified women who are now integral to our programme. Their skills range from sewing, felt making, and hand embroidery, to knitting."

The project features eight women who create diverse products from scratch: Elizabeth Mnwana, Emily Segame, Georgina Collins, Maserame Sebonyane, Nelly Olayi, Sarah Lenong, Sophia Mekhoe, and Ntabiseng Ndabeni.

She emphasises that the project also manufactures conference bags for various events and stands as one of UFS's most successful community initiatives. "Ultimately, this project has the potential to become self-sustaining, with proceeds supporting the salaries of the eight women," Vorster concludes.

Competition boosts visibility and market reach

Participating in initiatives like the OVK Innovation Competition motivates them to stay current and benchmark their efforts against other businesses or individuals involved in felt product creation.

"Winning a competition can also significantly uplift team morale," remarks Vorster.

"Securing second and third place in this competition translates to increased visibility and marketing opportunities for us. This is crucial as we aim to expand our market reach and establish a sustainable income stream for the project," she concludes.

A worker packs the carded wool in layers preparing for the felting process.

The cushion (in front), secured the team third place at the OVK Innovation Competition.

The lampshade secured the team second place at the OVK Innovation Competition.

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept